Serena Schiano
About Serena Schiano
Serena Schiano is a Senior Manager in Drug Product Development at KalVista Pharmaceuticals, Inc., where she has worked since 2021. She has a strong academic background in chemical engineering and chemistry, with previous roles in research and development at various institutions including the University of Surrey and Thermo Fisher Scientific.
Work at KalVista Pharmaceuticals
Serena Schiano currently holds the position of Senior Manager, Drug Product Development at KalVista Pharmaceuticals, Inc. She has been with the company since 2021, contributing to the development of innovative drug products. Her role involves overseeing various aspects of drug formulation and development, ensuring that projects align with regulatory standards and meet the needs of patients.
Previous Experience in Drug Development
Prior to her current role, Serena Schiano worked at Thermo Fisher Scientific as an R&D Project Manager/Technical Project Lead from 2018 to 2021. In this position, she managed research and development projects, focusing on technical aspects of drug product development. She also served as Research and Development Manager at Gamlen Tableting Limited for 10 months in 2017-2018, where she led initiatives in tablet formulation and manufacturing.
Academic Background and Research
Serena Schiano earned her Doctor of Philosophy (PhD) in Chemical Engineering from the University of Surrey, where she studied from 2013 to 2016. Prior to this, she completed her Laurea Magistrale in Scienze Chimiche at Università degli Studi di Napoli 'Federico II' from 2010 to 2012, and her Laurea Triennale in Chimica from 2006 to 2010 at the same institution. Her academic research has contributed to her expertise in drug formulation and development.
Postdoctoral Research Fellowship
From 2016 to 2017, Serena Schiano worked as a Postdoctoral Research Fellow at the University of Surrey for six months. During this time, she engaged in advanced research projects that enhanced her skills in scientific investigation and drug development methodologies, further solidifying her foundation in the field.